NEW YORK (GenomeWeb) – BioMérieux today reported that its second quarter revenues rose approximately 3 percent year over year. The firm attributed growth to a diversified geographic footprint and comprehensive offerings.

For the three months ended June 30, BioMérieux reported revenues of €582.2 million ($677.1 million), up from €566.4 million in the prior-year period. Organic growth, at constant exchange rates and scope of consolidation, was about 8 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.